Vext Science has EBITDA of $2.31M (U.S.) in Q3 2025

Mr. Eric Offenberger reports VEXT REPORTS Q3 2025 FINANCIAL RESULTS; REVENUE UP 41% YEAR-OVER-YEAR AND OPERATING CASH FLOW YEAR-TO-DATE REACHES $8.5 MILLION Vext Science Inc. has released its financial results for the period ended Sept. 30, 2025. All currency references used in this news release are in United States currency unless otherwise noted. Management commentary "Vext delivered another solid quarter, with revenue of $12.7-million, up 41 per cent year over year, and year-to-date operating cash flow of $8.5-million," said Eric Offenberger, chief executive officer of Vext. "Even with mixed market dynamics during the quarter, our operational discipline remained evident. Ohio continued to be a growth engine for Vext, with our expanded retail footprint and higher-margin channel mix contributing to meaningful year-over-year gains. In Arizona, our disciplined operations enabled us to continue to outperform state averages on a per-store basis and deliver steady performance despite a broader market decline. "For the remainder of 2025, we expect continued operational momentum and remain focused on maximizing performance across our five Ohio dispensaries, while advancing construction and licensing of the three additional locations planned for 2026. We continue to generate strong cash flow, and we expect Q4 cash flow to improve as we work through the inventory built in Q3. Over all, we're operating from a position of strength across both our core markets and remain well placed to leverage our vertically integrated platform and growing retail footprint to drive sustainable, profitable growth and create long-term value for shareholders," added Mr. Offenberger. Summary of recent announcements On Sept. 17, 2025, Vext announced that it has received regulatory approval from the Ohio Department of commerce to transfer ownership of the Herbal Wellness Center dispensary in Portsmouth, Ohio, to Vext. The company completed the closing and associated title transfers on Oct. 1, 2025. Q3 2025 financial results conference call The company will host a conference call and webcast on Thursday, Nov. 20, 2025, at 8 a.m. ET to discuss the financial results. Date:  Nov. 20, 2025 Time:  8 a.m. ET Participant dial-in:  1-647-849-3159 or 1-833-752-3966 Replay dial-in:   1-412-317-0088 or 1-855-669-9658 Conference ID:  10204616 Playback No.:  4318941 (expires on Dec. 4, 2025) About Vext Science Inc. Vext Science is a United States-based cannabis operator with vertical operations in Arizona and Ohio. Vext's expertise spans from cultivation through to retail operations in its key markets. Based out of Arizona, Vext owns and operates state-of-the-art cultivation facilities, fully built out manufacturing facilities as well as dispensaries in both Arizona and Ohio. The company manufactures Vapen, one of the leading THC concentrates, edibles and distillate cartridge brands in Arizona. Its selection of award-winning products are created with Vext's in-house, high-quality flower and distributed across Arizona and Ohio. Vext's leadership team brings a proven record of building and operating profitable multistate operations. The company's primary focus is to continue growing in its core states of Arizona and Ohio, bringing together cutting-edge science, manufacturing and marketing to provide a reliable and valuable customer experience while generating shareholder value. We seek Safe Harbor.